enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
8.57
+0.68 (8.62%)
May 6, 2026, 10:51 AM EDT - Market open
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $574.1 million as of May 6, 2026. Its market cap has increased by 182.25% in one year.
Market Cap
574.10M
Enterprise Value
286.06M
1-Year Change
182.25%
Ranking
Category
Stock Price
$8.57
Market Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has increased from $155.91M to $574.10M, an increase of 268.22%. That is a compound annual growth rate of 35.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 528.55M | -12.62% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 528.30M |
| Shattuck Labs | 523.03M |
| Verastem | 522.67M |
| Ovid Therapeutics | 507.00M |
| Upstream Bio | 506.65M |
| Zura Bio | 504.77M |
| Immix Biopharma | 502.55M |
| Valneva SE | 500.30M |